Compare AVDL & UAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVDL | UAA |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 1996 | N/A |
| Metric | AVDL | UAA |
|---|---|---|
| Price | $21.63 | $4.65 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 19 |
| Target Price | ★ $18.38 | $6.34 |
| AVG Volume (30 Days) | 2.1M | ★ 9.4M |
| Earning Date | 11-04-2025 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $248,517,000.00 | ★ $5,049,070,000.00 |
| Revenue This Year | $65.47 | N/A |
| Revenue Next Year | $30.88 | $1.54 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 79.88 | N/A |
| 52 Week Low | $6.38 | $4.13 |
| 52 Week High | $23.57 | $8.72 |
| Indicator | AVDL | UAA |
|---|---|---|
| Relative Strength Index (RSI) | 61.54 | 56.97 |
| Support Level | $21.36 | $4.26 |
| Resistance Level | $21.68 | $4.64 |
| Average True Range (ATR) | 0.12 | 0.14 |
| MACD | -0.12 | 0.03 |
| Stochastic Oscillator | 74.68 | 90.00 |
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and elsewhere. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. The Baltimore-based company was founded in 1996 and is led by controlling shareholder Kevin Plank.